CVE-2025-69602
Altumcode 66biolinks vulnerability
- Published28 Jan 2026
Description
A session fixation vulnerability exists in 66biolinks v62.0.0 by AltumCode, where the application does not regenerate the session identifier after successful authentication. As a result, the same session cookie value is reused for users logging in from the same browser, allowing an attacker who can set or predict a session ID to potentially hijack an authenticated session.
CVSS 3.1 breakdown
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:NAffected products
Remediation
No fixed version is recorded in the NVD data. Check the vendor advisory for the latest guidance.
Related CVEs
Recent high-severity vulnerabilities sharing a weakness type.
Frequently asked
Is CVE-2025-69602 being actively exploited?
CVE-2025-69602 is not in the CISA KEV catalog. A public exploit reference exists, so treat it as exploitable. Its EPSS exploit probability is 0.40%.
How severe is CVE-2025-69602?
CVE-2025-69602 has a CVSS 3.1 base score of 9.1, rated critical. EPSS estimates a 0.40% probability of exploitation.
Which products are affected by CVE-2025-69602?
Affected products include Altumcode 66biolinks.
How do I fix CVE-2025-69602?
Apply the vendor's patch or advisory guidance, then verify no affected versions remain across your devices.
How Secuno handles this
Secuno correlates vulnerabilities like CVE-2025-69602 against the real software inventory on every managed device, as each hourly inventory arrives. Rather than a static severity, each match is scored in context: exploit availability, EPSS, the asset's exposure, and business criticality decide where it lands in the queue. If an affected version is present anywhere across your portfolio, it surfaces automatically with a prioritised remediation path.
Data from the NVD, CISA KEV catalog and FIRST EPSS. CVSS 3.1 base score shown where available.